# CAMPBELL'S Co: overview

CPB · Nasdaq · CIK 16732 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Aug 3

Pages: [Overview](/companies/cpb.md) · [Financials](/companies/cpb/financials.md) · [Filings](/companies/cpb/filings.md) · [Insiders](/companies/cpb/insiders.md)

Latest reported revenue: [$2.14bn](/filings/0000016732-26-000026.md) for Q4 FY2026, three months to 2026-08-02, from the 10-K filed Sep 24, 2026 (XBRL us-gaap:Revenues, accession 0000016732-26-000026).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-10-27) | Q2 FY2025 (2025-01-26) | Q3 FY2025 (2025-04-27) | Q4 FY2025 (2025-08-03) | Q1 FY2026 (2025-11-02) | Q2 FY2026 (2026-02-01) | Q3 FY2026 (2026-05-03) | Q4 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,772](/filings/0000016732-25-000126.md) | [2,685](/filings/0000016732-26-000006.md) | [2,475](/filings/0000016732-26-000012.md) | [2,321 d](/filings/0000016732-26-000026.md) | [2,677](/filings/0000016732-25-000126.md) | [2,564](/filings/0000016732-26-000006.md) | [2,366](/filings/0000016732-26-000012.md) | [2,137 d](/filings/0000016732-26-000026.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.2%](/filings/0000016732-25-000126.md) | [12.2%](/filings/0000016732-26-000006.md) | [6.5%](/filings/0000016732-26-000012.md) | [11.6% d](/filings/0000016732-26-000026.md) | [12.6%](/filings/0000016732-25-000126.md) | [10.6%](/filings/0000016732-26-000006.md) | [10.1%](/filings/0000016732-26-000012.md) | [0.2% d](/filings/0000016732-26-000026.md) |
| Net margin | % | [7.9%](/filings/0000016732-25-000126.md) | [6.4%](/filings/0000016732-26-000006.md) | [2.7%](/filings/0000016732-26-000012.md) | [6.2% d](/filings/0000016732-26-000026.md) | [7.2%](/filings/0000016732-25-000126.md) | [5.7%](/filings/0000016732-26-000006.md) | [5.2%](/filings/0000016732-26-000012.md) | [(2.8%) d](/filings/0000016732-26-000026.md) |
| Diluted EPS | $ per share | [0.72](/filings/0000016732-25-000126.md) | [0.58](/filings/0000016732-26-000006.md) | [0.22](/filings/0000016732-26-000012.md) | not reported | [0.65](/filings/0000016732-25-000126.md) | [0.48](/filings/0000016732-26-000006.md) | [0.41](/filings/0000016732-26-000012.md) | not reported |
| Free cash flow | $m | [115](/filings/0000016732-25-000126.md) | [411 d](/filings/0000016732-26-000006.md) | [50.0 d](/filings/0000016732-26-000012.md) | [129 d](/filings/0000016732-26-000026.md) | [97.0](/filings/0000016732-25-000126.md) | [416 d](/filings/0000016732-26-000006.md) | [29.0 d](/filings/0000016732-26-000012.md) | [136 d](/filings/0000016732-26-000026.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-07-31) | FY2023 (2023-07-30) | FY2024 (2024-07-28) | FY2025 (2025-08-03) | FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.6](/filings/0000016732-24-000130.md) | [9.4](/filings/0000016732-25-000112.md) | [9.6](/filings/0000016732-26-000026.md) | [10.3](/filings/0000016732-26-000026.md) | [9.7](/filings/0000016732-26-000026.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.6%](/filings/0000016732-24-000130.md) | [14.0%](/filings/0000016732-25-000112.md) | [10.4%](/filings/0000016732-26-000026.md) | [11.0%](/filings/0000016732-26-000026.md) | [8.7%](/filings/0000016732-26-000026.md) |
| Net margin | % | [8.8%](/filings/0000016732-24-000130.md) | [9.2%](/filings/0000016732-25-000112.md) | [5.9%](/filings/0000016732-26-000026.md) | [5.9%](/filings/0000016732-26-000026.md) | [4.1%](/filings/0000016732-26-000026.md) |
| Diluted EPS | $ per share | [2.51](/filings/0000016732-24-000130.md) | [2.85](/filings/0000016732-25-000112.md) | [1.89](/filings/0000016732-26-000026.md) | [2.01](/filings/0000016732-26-000026.md) | [1.31](/filings/0000016732-26-000026.md) |
| Free cash flow | $bn | [0.9](/filings/0000016732-24-000130.md) | [0.8](/filings/0000016732-25-000112.md) | [0.7](/filings/0000016732-26-000026.md) | [0.7](/filings/0000016732-26-000026.md) | [0.7](/filings/0000016732-26-000026.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cpb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $650.8m | 29,225,401 |  | Added +12,112,696 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $276.6m | 12,422,314 |  | Added +2,414,925 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $206.1m | 9,255,680 |  | Reduced −3,904,839 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $190.5m | 8,554,455 |  | Reduced −1,684,776 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $179.2m | 8,046,417 |  | Added +94,907 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $173.3m | 7,782,642 |  | Reduced −4,727,101 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $157.6m | 7,076,660 |  | Added +659,719 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $144.1m | 6,471,754 |  | Added +772,562 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $141.1m | 6,334,950 |  | Added +6,167,736 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $110.1m | 4,942,269 |  | Added +2,939,907 |

## Recent filings

[All 1,611 filings](/companies/cpb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 12:55 ET | [DEF 14A](/filings/0000016732-26-000031.md) | Proxy statement, period 2026-11-17 | 0000016732-26-000031 |
| 2026-10-05 | 20:08 ET | [8-K](/filings/0001193125-26-414113.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-414113 |
| 2026-09-24 | 11:33 ET | [10-K](/filings/0000016732-26-000026.md) | Annual report, period 2026-08-02 | 0000016732-26-000026 |
| 2026-09-17 | 20:09 ET | [8-K](/filings/0000016732-26-000023.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000016732-26-000023 |
| 2026-09-03 | 11:17 ET | [8-K](/filings/0000016732-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000016732-26-000020 |
| 2026-06-17 | 20:38 ET | [8-K](/filings/0000016732-26-000014.md) | 5.02 Departure or appointment of officers or directors | 0000016732-26-000014 |
| 2026-06-08 | 11:26 ET | [10-Q](/filings/0000016732-26-000012.md) | Quarterly report, period 2026-05-03 | 0000016732-26-000012 |
| 2026-06-08 | 11:17 ET | [8-K](/filings/0000016732-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000016732-26-000010 |
| 2026-03-11 | 11:23 ET | [10-Q](/filings/0000016732-26-000006.md) | Quarterly report, period 2026-02-01 | 0000016732-26-000006 |
| 2026-03-11 | 11:17 ET | [8-K](/filings/0000016732-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000016732-26-000004 |

## Latest annual report

[Form 10-K for the fiscal year ended Aug 2, 2026](/filings/0000016732-26-000026.md), filed Sep 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 16732
- Tickers: CPB
- Exchange: Nasdaq
- SIC code: 2000 Food and Kindred Products
- State of incorporation: NJ
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.